Skip to main content

Advertisement

Springer Nature Link
Log in

Multi-objective optimal chemotherapy control model for cancer treatment

  • Original Article
  • Published:
Medical & Biological Engineering & Computing Aims and scope Submit manuscript

Abstract

This article presents an investigation into the development of a multi-objective optimal chemotherapy control model to reduce the number of cancer cells after a number of fixed treatment cycles with minimum side effects. Mathematical models for cancer chemotherapy are designed to predict the number of tumour cells and control the tumour growth during treatment. This requires an understanding of the system in the absence of treatment and a description of the effects of the treatment. In order to achieve multi-objective optimal control model, we used the proportional, integral and derivative (PID) and I-PD (modified PID with Integrator used as series) controllers based on Martin’s model for drug concentration. To the best of our knowledge, this is the first PID/IPD-based optimal chemotherapy control model used to investigate the cancer treatment. The proposed control schemes are designed based on the optimal solution of three objective functions, which include (i) maximising tumour cell killing, for (ii) minimum toxicity, and (iii) tolerable drug concentration. Multi-objective genetic algorithm (MOGA) is used to find suitable parameters of controllers that trade-off among design objectives considered in this work. The results of the different optimal scheduling patterns of the proposed models are presented and discussed through a set of experiments. Finally, the observations are compared with the existing models in order to demonstrate the merits and capabilities of the proposed multi-objective optimisation models. It is noted that the proposed model offers best performance as compared to any models reported earlier.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Abundo M, Rossi C (1989) Numerical simulation of a stochastic model for cancerous cells submitted to chemotherapy. J Math Biol 27:81–90

    CAS  PubMed  Google Scholar 

  2. Astrom H, Hagglund T, Hang C, Ho W (1993) Automatic tuning and adaptation for PID controller a survey. IFACJ Control Eng Prac 1(4):699–714

    Article  Google Scholar 

  3. Bojkov B, Hansel R, Luus R (1993) Application of direct search optimization to optimal control problems. Hung J Ind Chem 21:177–185

    CAS  Google Scholar 

  4. Booker B (1987) Improving search in genetic algorithms. Genetic algorithms and simulated annealing. Morgan Kaufmann, Los Altos

    Google Scholar 

  5. Brandt K, Gastens A, Loscher W (2006) The multidrug transporter hypothesis of drug resistance in epilepsy: proof-of-principle in a rat model of temporal lobe epilepsy. Neurobiol Dis 24:202–211

    Article  CAS  PubMed  Google Scholar 

  6. Carrasco E, Banga JR (1997) Dynamic optimization of batch reactors using adaptive stochastic algorithms. Ind Eng Chem Res 36:2252–2261

    Article  CAS  Google Scholar 

  7. Chen K, Calzone L, Nagy A, Cross F, Novak B, Tyson J (2004) Integrative analysis of cell cycle control in budding yeast molecular biology of the cell. Am Soc Cell Biol 15:3841–3862

    CAS  Google Scholar 

  8. Chipperfield A, Fleming P, Pohlheim H, Fonseca C (1994) Genetic algorithms toolbox user’s guide. Automatic control and systems engineering. The University of Sheffield, UK

    Google Scholar 

  9. Costa L, Bassanezi RC (1992) Optimal chemical control of populations developing drug resistance. IMA J 9:215–226

    CAS  Google Scholar 

  10. Deb K (2001) Multi-objective optimisation using evolutionary algorithms. Wiley, New York

    Google Scholar 

  11. Dua P, Dua V, Pistikopoulos N (2007) Optimal delivery of chemotherapeutic agents in cancer. Comput Chem Eng 32:99–107

    Article  Google Scholar 

  12. E. Baker, “Reducing bias and inefficiency in the selection algorithm.”, The Second International Conference on Genetic Algorithms, San Mateo, Morgan Kaufmann, Inc, 1987

  13. Fonseca C (1995) Multiobjective genetic algorithms with application to control engineering problems. PhD thesis, Department of Automatic Control and Systems Engineering, The University of Sheffield, UK

  14. Fonseca CM, Fleming PJ (1993) Genetic algorithm for multiobjective optimization, formulation, discussion and generalization. In: Forrest S (ed) Genetic algorithms: proceeding of the fifth international conference, CA, pp 416–423

  15. Fonseca C, Fleming P (1998) Multiobjective optimization and multiple constraint handling with evolutionary algorithms-part I: a unified formulation. IEEE Trans Syst Man Cybern A 28(1): 26–37

    Google Scholar 

  16. Goldberg D (1989) Genetic algorithms in search, optimisation and machine learning. Addison Wesley Longman Publishing Co. Inc., New York

    Google Scholar 

  17. Handl J, Kell DB, Knowles J (2007) Multiobjective optimization in bioinformatics and computational biology. IEEE/ACM Trans Comput Biol Bioinf 4:279–292

    Article  CAS  Google Scholar 

  18. Holland J (1975) Adaptation in natural and artificial system. University of Michigan Press, Ann Arbor

  19. Kiran K, Jayachandran D, Lakshminarayanan S (2008) Multi-objective optimization of cancer immuno-chemotherapy. ICBME. Springer, Berlin 1337–1340

  20. Kozusko Z (2003) Combining Gompertzian growth and cell population dynamics. Math Biosci 185:153–167

    Article  PubMed  Google Scholar 

  21. Ledzewicz U, Schattler U, Marriott J (2009) Piecewise constant suboptimal controls for a system describing tumor growth under angiogenic treatment. In: 18th IEEE international conference on control applications, pp 77–82

  22. Ledzewicz U, Schattler U, Berman A (2009) On the structure of optimal controls for a mathematical model of tumour anti-angiogenic therapy with linear pharmacokinetics. In: 18th IEEE international conference on control application, pp 71–76

  23. Liang Y, Leung KS, Mok SK (2004) Evolutionary drug scheduling models for cancer chemotherapy. In: Proceedings of the international conference GECCO, pp 1126–1137

  24. Liang Y, Leung K-S, Mok TSK (2006) A novel evolutionary drug scheduling model in cancer chemotherapy. IEEE Trans Inf Technol Biomed 1:237–245

    Article  Google Scholar 

  25. Liang Y, Leung K, Mok T (2008) Evolutionary drug scheduling models with different toxicity metabolism in cancer chemotherapy. Appl Soft Comput 8:140–149

    Article  Google Scholar 

  26. Luus R, Hartig F, Keil F (1995) Optimal drug scheduling of cancer chemotherapy by direct search optimization. Hung J Ind Chem 23:55–58

    CAS  Google Scholar 

  27. Martin R (1992) Optimal control drug scheduling of cancer chemotherapy. Automatica 28:1113–1123

    Article  Google Scholar 

  28. Martin R, Teo KL (1994) Optimal control of drug administration in chemotherapy tumour growth. World Scientific, Singapore, pp 1–10

    Google Scholar 

  29. McCall J, Petrovski A, Shakya A (2008) Evolutionary algorithms for cancer chemotherapy optimization. In: Fogel GB, Corne DW, Pan Y (eds) Computational intelligence in bioinformatics. IEEE press series in computational intelligence. Wiley, New York, pp 265–296

  30. Panetta J (1999) A mathematical model of drug resistance: heterogeneous tumour. Math Biosci 147:41–61

    Article  Google Scholar 

  31. Petrovski A, Sudha B, McCall J (2004) Optimising cancer chemotherapy using particle swarm optimization and genetic algorithms. In: Proceedings of the 8th international conference on parallel problem solving from nature, vol 3242. Lecture notes in computer science. Springer, Berlin, 633–641

  32. Pierre C, Etienne C, Sylvie G (1998) Practical treatment guide for dose individualisation in cancer chemotherapy. Drugs 56(6):1019–1038

    Article  Google Scholar 

  33. Ruotsalainen H, Boman E, Miettinen K, Tervo J (2009) Nonlinear interactive multiobjective optimization method for radiotherapy treatment planning with Boltzmann transport equation. Contemp Eng Sci 2(9):391–422

    Google Scholar 

  34. Souslova T, Averill-Bates DA (2004) Multidrug-resistant hela cells overexpressing MRP1 exhibit sensitivity to cell killing by hyperthermia: interactions with etoposide. Int J Radiat Oncol Biol Phys 60(5):1538–1551

    Article  CAS  PubMed  Google Scholar 

  35. Tan K, Khor EF, Cai J, Heng CM, Lee TH (2002) Automating the drug scheduling of cancer chemotherapy via: evolutionary computation. Artif Intell Med 1:908–913

    Google Scholar 

  36. Tes S, Liang Y, Leung K-S, Lee K, Mok TSK (2007) A memetic algorithm for multiple-drug cancer chemotherapy scheduling optimization. IEEE Trans Syst Man Cybern B 37:84–91

    Article  Google Scholar 

  37. The Mathworks (2010a) MATLAB reference guide

  38. Vahedi G, Faryabi B, Chamberland J, Datta A (2009) Optimal intervention strategies for cyclic therapeutic methods. IEEE Trans Biomed Eng 56:281–291

    PubMed  Google Scholar 

  39. Westman J, Fabijonas BR, Kern DL, Hanson FB (2001) Compartmental model for cancer evolution: chemotherapy and drug resistance. Math Biosci (submitted)

  40. Woderz N (2005) Computational biology of cancer lecture notes and mathematical modelling. World Scientific, Singapore, pp 1–10

    Book  Google Scholar 

  41. Zhao J, Zhu YM, Song P, Fang Q, Luo J (2005) Recognition of gene acceptor site based on multi-objective optimization. Acta Biochim Biophys Sin 37:435–439

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Computing, University of Bradford, Bradford, BD 7 1DP, UK

    S. Algoul & M. A. Hossain

  2. Department of Applied Physics, Electronics and Communication Engineering, University of Dhaka, Dhaka, Bangladesh

    M. S. Alam

  3. School of Life Science, University of Bradford, Bradford, BD7 1DP, UK

    M. A. A. Majumder

Authors
  1. S. Algoul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. S. Alam
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. A. Hossain
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. A. A. Majumder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. A. Hossain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Algoul, S., Alam, M.S., Hossain, M.A. et al. Multi-objective optimal chemotherapy control model for cancer treatment. Med Biol Eng Comput 49, 51–65 (2011). https://doi.org/10.1007/s11517-010-0678-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11517-010-0678-y

Keywords

Search

Navigation

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy